Safety 98% Flibanserin Raw Sex Powder Flibanserin 167933-07-5 Viagra for Women
Quick Details for Flibanserin
Flibanserin Synonyms: Flibanserin;Bimt 17;
Flibanserin CAS: 167933-07-5
Flibanserin MF: C20H21F3N4O
Flibanserin MW: 390.4
Flibanserin Appearance: White powder
Grade: Pharmaceutical grade
Usage: HSDD is the most commonly reported form of female sexual dysfunction. HSDD is defined as a persistent or recurrent deficiency or absence of sexual fantasies and desire for sexual activity that causes marked distress or interpersonal difficulty, and which is not better accounted for by a medical, substance-related, psychiatric (e. G., depression) or other sexual condition. The cause of HSDD is believed to involve a multitude of social, psychological and biological factors and may be attributed to a complex interplay of these factors.
Adrug being studied as a non-hormonal treatment for pre-menopausal women with hypoactive sexual desire disorder (HSDD).
Applications: A new drug designed to boost sexual desire in women is controversial for some and eagerly awaited by others, but it’s hit a potentially serious snag. The drug didn’t boost women’s desire any more than a placebo in two clinical trials. The Food and Drug Administration posted the clinical trial results on its website today in advance of a committee meeting on Friday, when a panel of experts will vote whether or not to recommend approval of the drug called flibanserin. (The FDA usually follows the recommendations of its expert panels. ) Although there was a slight increase in the number of sexually satisfying events flibanserin users had each month, the FDA staff who reviewed the results said the so-called response rate isn’t “particularly compelling. ”
It’s called the “little pink pill, ” a tiny tablet that could have a huge impact on treating female sexual dysfunction. If it’s approved, it would become the first drug of its kind on the market.
Sex Steroid Hormones Dosage
(1) Recommended dosage is 100 mg taken once daily at bedtime.
(2) Taking it at night reduces the risk of sleepiness, low blood pressure, and fainting during waking hours.
(3) If your symptoms do not improve after 8 weeks of treatment, stop treatment and call your doctor.
(4) If a dose is missed at bedtime, take the next dose at bedtime the following day. Do not take a double
dose to make up for a missed one.